Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam Study).
暂无分享,去创建一个
A. Hofman | J. Witteman | B. Stricker | J. Deckers | C. V. van Duijn | J. Janssen | E. V. van Rossum | I. Rietveld | G. Bleumink | A. Hofman | C. V. van Duijn
[1] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[2] A. Hofman,et al. A polymorphic CA repeat in the IGF‐I gene is associated with gender‐specific differences in body height, but has no effect on the secular trend in body height , 2004, Clinical endocrinology.
[3] A. Hofman,et al. Determinants of disease and disability in the elderly: The Rotterdam elderly study , 1991, European Journal of Epidemiology.
[4] Ralph D'Agostino,et al. Serum Insulin-like Growth Factor I and Risk for Heart Failure in Elderly Individuals without a Previous Myocardial Infarction: The Framingham Heart Study , 2003, Annals of Internal Medicine.
[5] A. Hofman,et al. Polymorphism in the Promoter Region of the Insulin-like Growth Factor I Gene Is Related to Carotid Intima-Media Thickness and Aortic Pulse Wave Velocity in Subjects With Hypertension , 2003, Stroke.
[6] A. Hofman,et al. A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. , 2003, European journal of endocrinology.
[7] A. Ruiz-Torres,et al. Ageing and Longevity Are Related to Growth Hormone/Insulin-Like Growth Factor-1 Secretion , 2002, Gerontology.
[8] F. Speizer,et al. A sequence repeat in the insulin‐like growth factor‐1 gene and risk of breast cancer , 2002, International journal of cancer.
[9] Yoav Ben-Shlomo,et al. A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. , 2002, Diabetes.
[10] S. Lamberts,et al. The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: is prevention possible? , 2002, European journal of endocrinology.
[11] K. Swedberg,et al. Comprehensive guidelines for the diagnosis and treatment of chronic heart failure Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology , 2002, European journal of heart failure.
[12] K. Swedberg,et al. Guidelines for the diagnosis and treatment of chronic heart failure. , 2001, European heart journal.
[13] A. Hofman,et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. , 2001, Diabetes.
[14] J. Sowers,et al. Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease. , 1999, Journal of molecular and cellular cardiology.
[15] J. Bilezikian,et al. Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. , 1998, The Journal of clinical endocrinology and metabolism.
[16] J. Kaprio,et al. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. , 1996, The Journal of clinical investigation.